NutriBand (NTRB) Total Liabilities (2016 - 2026)
NutriBand (NTRB) posted Total Liabilities of $902312.0 for Q2 2026, up 3.9% sequentially from $868447.0 in Q1 2026, and down 13.97% YoY from $1.0 million in Q2 2025.
NutriBand (NTRB) Total Liabilities (2016 - 2026) Analysis & Trends
NutriBand has reported Total Liabilities for 11 years, with the latest figure at $902312.0 in Q2 2026.
- Quarterly Total Liabilities fell 13.97% year-over-year to $902312.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $902312.0 (down 13.97% YoY) and the FY2026 annual result came in at $868447.0, down 16.58% from the prior year.
- Total Liabilities grew to $902312.0 in Q2 2026 per NTRB's latest filing, from $868447.0 in the prior quarter.
- Over five years, Total Liabilities peaked at $3.0 million in Q3 2023 and troughed at $868447.0 in Q1 2026.
- A 5-year average of $1.3 million and a median of $1.0 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities sank 68.73% in 2022, then soared 202.66% in 2023.
- Over 5 years, Total Liabilities stood at $937633.0 in 2022, then jumped by 199.88% to $2.8 million in 2023, then sank by 53.36% to $1.3 million in 2024, then slumped by 33.65% to $870208.0 in 2025, then advanced by 3.69% to $902312.0 in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $902312.0, $868447.0, and $870208.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 10.03 Bn |
| 10 | NutriBand | 54.82 Mn | 50.82 Mn | 196,801.00 | 902,312.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 902,312.00 |
| Jan 31, 2026 | 868,447.00 |
| Oct 31, 2025 | 870,208.00 |
| Jul 31, 2025 | 1.68 Mn |
| Apr 30, 2025 | 1.05 Mn |
| Jan 31, 2025 | 1.04 Mn |
| Oct 31, 2024 | 1.31 Mn |
| Jul 31, 2024 | 1.17 Mn |
| Apr 30, 2024 | 1.79 Mn |
| Jan 31, 2024 | 1.08 Mn |
| Oct 31, 2023 | 2.81 Mn |
| Jul 31, 2023 | 2.98 Mn |
| Apr 30, 2023 | 955,821.00 |
| Jan 31, 2023 | 883,387.00 |
| Oct 31, 2022 | 937,633.00 |
| Jul 31, 2022 | 985,242.00 |
| Apr 30, 2022 | 904,375.00 |
| Jan 31, 2022 | 880,375.00 |
| Oct 31, 2021 | 1.11 Mn |
| Jul 31, 2021 | 2.85 Mn |